Thomas Catinazzo
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Thomas Catinazzo is currently Chief Financial Officer at Relay Therapeutics, Inc. since 2022.
Formerly, Mr. Catinazzo was Vice President-Financial Planning & Analysis at Foundation Medicine, Inc. from 2017 to 2018.
Education includes an undergraduate degree from Boston College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-06-2026 | 177.461 ( 0,09% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-04-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01-04-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau